Bausch Health Lifts 2026 Guidance After Quarterly Adjusted Earnings Jump 53%
Bausch Health Companies Inc. raised its full-year 2026 revenue and adjusted EBITDA guidance after reporting a 53% jump in third-quarter adjusted earnings per share to $1.77, significantly beating analyst expectations. Revenue also climbed 10% to $2.941 billion, surpassing estimates, and net income more than doubled. The company also announced a $50 million share buyback program and noted that its Adjusted EBITDA excluding Bausch + Lomb exceeded $1 billion for the first time.
Put this headline into context
Use TradingAgents AI to connect the story to the company's filings, fundamentals, market structure, competing bull and bear arguments, and risk review.
Headlines and excerpts belong to the original publisher. Ticker associations are informational and may be incomplete. Market news is not personalized financial advice.